Timothy is a Life Sciences Commercialization Strategist and the Executive Director, Early Asset TA Lead- Oncology at Boehringer Ingelheim. With an MBA from Davenport University, he specializes in accelerating market delivery for assets in oncology, neurology, and immunology by leading clinical development, payer strategy, and digital transformation.
Outside of his professional focus on oncology and pharmaceuticals, he likely maintains an interest in the community and teams connected to his time in Michigan, where he attended both Eastern Michigan University and Davenport University.
He authored a white paper on the critical success factors for launching products with accelerated designations like Fast Track, PRIME, and ILAP.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.